Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy?
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Due to system maintenance, login and edit functionaility is currently unavailable
Return to Top
Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy?
Can low-risk, early-stage patients with Hodgkin lymphoma be spared radiotherapy? Curr Hematol Malig Rep. 2011 Sep; 6(3):180-6.
View in:
PubMed
subject areas
Antineoplastic Agents
Breast Neoplasms
Clinical Trials as Topic
Combined Modality Therapy
Female
Hodgkin Disease
Humans
Neoplasm Staging
authors with profiles
Gregory Michael Cote, M.D.
George Peter Canellos, M.D.